Skip to main content

Tussnex FM Severe cough and congestion

NDC 53041-617 · Guardian Drug Company

Generic nameDextromethorphan HBr, Guaifenesin, Phenylephrine HCl
Dosage formLIQUID
RouteORAL
Active ingredient(s)DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE
Strength20; 400; 10 mg/20mL; mg/20mL; mg/20mL
Pharmacologic classAdrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
Marketing categoryOTC MONOGRAPH DRUG

Packages

53041-617-58 — 177 mL in 1 BOTTLE (53041-617-58)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

52412-920 — BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE, 52412-992 — DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN, 52747-475 — acetaminophen, chlorpheniramine maleate, and phenylephrine HCl, 53041-190 — Guaifenesin, 53041-191 — Guaifenesin, 53041-233 — Guaifenesin, 53041-234 — Guaifenesin, 53041-577 — Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl, 53041-615 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 53041-616 — Acteaminophen, Guaifenesin, Phenylephrine HCl, 53041-618 — Acteaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 53041-622 — Acteaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 53041-628 — Dextromethorphan HBr, Guaifenesin, 53113-514 — Dextromethorphan Hydrobromide, Guaifenesin, 53113-515 — Dextromethorphan Hydrobromide, Guaifenesin, 53145-005 — Acetaminophen, Chlorpherinamine maleate, Phenylephrine HCI, 53145-009 — Acetaminophen, Diphenhydramine HCl, Phenylephrine HCI, 53145-026 — DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, 53145-039 — Guaifenesin, Dextromethorphan HBR, 53145-059 — Dextromethorphan HBR, Guaifenesin, +3082 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels